Customer income almost doubled from previous 2 quarters and when Australia gets Viraleze in pharmacies the sales will leap, lots of repressed demand
Good that CEO clarified that a submission was made pre TGA Delegate final decision 1 June 2024. It will be interesting to read that submission if not too much gets redacted or it gets marked as confidential submission. Will they argue for not mentioning covid use ? How will the marketed product be labeled. In a month we should know.
Also will TGA remove the Australian IP address blockages
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-14
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.001(1.01%) |
Mkt cap ! $43.26M | |||
| Open | High | Low | Value | Volume |
| 9.9¢ | 10.5¢ | 9.9¢ | $19.52K | 195.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 286 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 432012 | 9 |
View Market Depth
| Last trade - 13.51pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
10.0¢ |
Change
0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 9.9¢ | 10.0¢ | 9.8¢ | 101068 | ||
| Last updated 11.39am 14/06/2024 ? | |||||
| SPL (ASX) Chart |